VYNT-0126
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for VYNT-0126, covering 2022-11-23 to 2022-11-23. Get the full timeline:
Most recent: Clinical Trial Update: Study of VYNT-0126 in the Treatment of Rett Syndrome in Adult Patients [Phase 2]